BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35047578)

  • 21. Risk factors for the development of atrial fibrillation on ibrutinib treatment.
    Lentz R; Feinglass J; Ma S; Akhter N
    Leuk Lymphoma; 2019 Jun; 60(6):1447-1453. PubMed ID: 30730240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)-an analysis of an administrative health claims database.
    Vallabhaneni S; Adusumalli S; Wu J; Groeneveld PW; Gerson J; O'Quinn RP
    Cardiooncology; 2024 Jun; 10(1):33. PubMed ID: 38824606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
    Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
    Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmias in Patients on Maintenance Dialysis: A Cross-sectional Study.
    Rantanen JM; Riahi S; Schmidt EB; Johansen MB; Søgaard P; Christensen JH
    Am J Kidney Dis; 2020 Feb; 75(2):214-224. PubMed ID: 31542235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.
    Reda G; Fattizzo B; Cassin R; Mattiello V; Tonella T; Giannarelli D; Massari F; Cortelezzi A
    J Hematol Oncol; 2018 Jun; 11(1):79. PubMed ID: 29891001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Detection of Symptomatic Paroxysmal Cardiac Arrhythmias by Trans-Telephonic ECG Monitoring: Impact on Diagnosis and Treatment of Atrial Fibrillation.
    Anczykowski J; Willems S; Hoffmann BA; Meinertz T; Blankenberg S; Patten M
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1032-7. PubMed ID: 27257094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of new-onset cardiomyopathy and ventricular tachycardia in a patient receiving ibrutinib for relapsed mantle cell lymphoma.
    Wallace N; Wong E; Cooper D; Chao H
    Clin Case Rep; 2016 Dec; 4(12):1120-1121. PubMed ID: 27980745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidden burden of arrhythmias in patients with small atrial septal defects: a nationwide study.
    Udholm S; Nyboe C; Redington A; Nielsen-Kudsk JE; Nielsen JC; Hjortdal VE
    Open Heart; 2019; 6(1):e001056. PubMed ID: 31328006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.
    Page RL; Wilkinson WE; Clair WK; McCarthy EA; Pritchett EL
    Circulation; 1994 Jan; 89(1):224-7. PubMed ID: 8281651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilizing left atrial strain to identify patients at risk for atrial fibrillation on ibrutinib.
    Singh A; El Hangouche N; McGee K; Gong FF; Lentz R; Feinglass J; Akhter N
    Echocardiography; 2021 Jan; 38(1):81-88. PubMed ID: 33594858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic yield of asymptomatic arrhythmias detected by mobile cardiac outpatient telemetry and autotrigger looping event cardiac monitors.
    Derkac WM; Finkelmeier JR; Horgan DJ; Hutchinson MD
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1475-1478. PubMed ID: 28940881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Types and risk factors of arrhythmia on young patients with acute coronary syndrome in Henan province].
    Zhao J; He F; Hu DY; Ding RJ; Yu XJ; Gou JJ; Wang L; Zhang P; Li XB; Guo JH; Liu WL; Li CL; Li L; Gao CY; Zhao LS; Chu YJ; Huang ZW; Wei JH; Hua SH; Liu RY; Zhuang XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):572-6. PubMed ID: 24284184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of external cardioversion induced atrial tachyarrhythmias.
    Brembilla-Perrot B; Beurrier D; Houriez P; De La Chaise AT; Louis P; Nippert M; Muhanna Y; Selton-Suty C; Sadoul N; Andronache M
    Pacing Clin Electrophysiol; 2003 Nov; 26(11):2111-5. PubMed ID: 14622312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
    Archibald WJ; Rabe KG; Kabat BF; Herrmann J; Ding W; Kay NE; Kenderian SS; Muchtar E; Leis JF; Wang Y; Chanan-Khan AA; Schwager SM; Koehler AB; Fonder AL; Slager SL; Shanafelt TD; Call TG; Parikh SA
    Ann Hematol; 2021 Jan; 100(1):143-155. PubMed ID: 32488603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias.
    Ozcan C; Strom JB; Newell JB; Mansour MC; Ruskin JN
    Europace; 2014 Oct; 16(10):1508-14. PubMed ID: 24906607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias and sudden death events following acalabrutinib initiation.
    Bhat SA; Gambril J; Azali L; Chen ST; Rosen L; Palettas M; Wiczer TE; Kalathoor S; Zhao Q; Rogers KA; Kittai A; Grever M; Awan F; Ruz P; Byrd JC; Woyach J; Addison D
    Blood; 2022 Nov; 140(20):2142-2145. PubMed ID: 35917449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.